Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WelChol Add-on to Metformin in T2D
NCT00147719Phase 3Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2004
- Primary completion
- Jul 2006
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Colesevelam + Metformin with Placebo + Metformin (2 arms). Primary endpoint: Change in Hemoglobin A1c at 26 weeks. Started Jun 2004; status: completed.
02
Drugs
colesevelam
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00147719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00147719.